- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 4 residues within 4Å:- Chain A: D.2, F.3, N.5, N.154
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:D.2
NAG-NAG.8: 4 residues within 4Å:- Chain B: D.2, F.3, N.5, N.154
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:D.2
NAG-NAG.14: 4 residues within 4Å:- Chain C: D.2, F.3, N.5, N.154
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:D.2
NAG-NAG.20: 4 residues within 4Å:- Chain D: D.2, F.3, N.5, N.154
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:D.2
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.3: 2 residues within 4Å:- Chain A: N.65, W.357
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.65, A:W.357
NAG.9: 2 residues within 4Å:- Chain B: N.65, W.357
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.65, B:W.357
NAG.15: 2 residues within 4Å:- Chain C: N.65, W.357
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.65, C:W.357
NAG.21: 2 residues within 4Å:- Chain D: N.65, W.357
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:N.65, D:W.357
- 8 x CA: CALCIUM ION(Non-covalent)(Non-functional Binders)
CA.4: 5 residues within 4Å:- Chain A: D.213, G.217, D.244, N.266, G.267
5 PLIP interactions:3 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.213, A:G.217, A:D.244, H2O.3, H2O.14
CA.5: 3 residues within 4Å:- Ligands: CA.11, CA.17, CA.23
No protein-ligand interaction detected (PLIP)CA.10: 5 residues within 4Å:- Chain B: D.213, G.217, D.244, N.266, G.267
5 PLIP interactions:3 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.213, B:G.217, B:D.244, H2O.17, H2O.28
CA.11: 3 residues within 4Å:- Ligands: CA.5, CA.17, CA.23
No protein-ligand interaction detected (PLIP)CA.16: 5 residues within 4Å:- Chain C: D.213, G.217, D.244, N.266, G.267
5 PLIP interactions:3 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:D.213, C:G.217, C:D.244, H2O.31, H2O.42
CA.17: 3 residues within 4Å:- Ligands: CA.5, CA.11, CA.23
No protein-ligand interaction detected (PLIP)CA.22: 5 residues within 4Å:- Chain D: D.213, G.217, D.244, N.266, G.267
5 PLIP interactions:3 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:D.213, D:G.217, D:D.244, H2O.45, H2O.56
CA.23: 3 residues within 4Å:- Ligands: CA.5, CA.11, CA.17
No protein-ligand interaction detected (PLIP)- 4 x 9AM: 9-AMINO-2-DEOXY-2,3-DEHYDRO-N-ACETYL-NEURAMINIC ACID(Non-covalent)
9AM.6: 14 residues within 4Å:- Chain A: R.37, E.38, D.70, R.71, W.98, I.142, R.144, A.166, E.196, E.197, R.212, N.214, R.290, Y.324
16 PLIP interactions:16 interactions with chain A- Hydrophobic interactions: A:W.98, A:I.142, A:R.144
- Hydrogen bonds: A:E.38, A:R.71, A:E.196, A:E.197, A:R.212
- Water bridges: A:R.37, A:E.147, A:E.147, A:E.197, A:E.197
- Salt bridges: A:R.37, A:R.212, A:R.290
9AM.12: 14 residues within 4Å:- Chain B: R.37, E.38, D.70, R.71, W.98, I.142, R.144, A.166, E.196, E.197, R.212, N.214, R.290, Y.324
16 PLIP interactions:16 interactions with chain B- Hydrophobic interactions: B:W.98, B:I.142, B:R.144
- Hydrogen bonds: B:E.38, B:R.71, B:E.196, B:E.197, B:R.212
- Water bridges: B:R.37, B:E.147, B:E.147, B:E.197, B:E.197
- Salt bridges: B:R.37, B:R.212, B:R.290
9AM.18: 14 residues within 4Å:- Chain C: R.37, E.38, D.70, R.71, W.98, I.142, R.144, A.166, E.196, E.197, R.212, N.214, R.290, Y.324
16 PLIP interactions:16 interactions with chain C- Hydrophobic interactions: C:W.98, C:I.142, C:R.144
- Hydrogen bonds: C:E.38, C:R.71, C:E.196, C:E.197, C:R.212
- Water bridges: C:R.37, C:E.147, C:E.147, C:E.197, C:E.197
- Salt bridges: C:R.37, C:R.212, C:R.290
9AM.24: 14 residues within 4Å:- Chain D: R.37, E.38, D.70, R.71, W.98, I.142, R.144, A.166, E.196, E.197, R.212, N.214, R.290, Y.324
16 PLIP interactions:16 interactions with chain D- Hydrophobic interactions: D:W.98, D:I.142, D:R.144
- Hydrogen bonds: D:E.38, D:R.71, D:E.196, D:E.197, D:R.212
- Water bridges: D:R.37, D:E.147, D:E.147, D:E.197, D:E.197
- Salt bridges: D:R.37, D:R.212, D:R.290
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Smith, B.J. et al., Analysis of inhibitor binding in influenza virus neuraminidase. Protein Sci. (2001)
- Release Date
- 2001-04-11
- Peptides
- NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x CA: CALCIUM ION(Non-covalent)(Non-functional Binders)
- 4 x 9AM: 9-AMINO-2-DEOXY-2,3-DEHYDRO-N-ACETYL-NEURAMINIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Smith, B.J. et al., Analysis of inhibitor binding in influenza virus neuraminidase. Protein Sci. (2001)
- Release Date
- 2001-04-11
- Peptides
- NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A